wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30423909-A737501C-33A8-40CE-BBA9-3544CDABB80D
Q30423909-A737501C-33A8-40CE-BBA9-3544CDABB80D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30423909-A737501C-33A8-40CE-BBA9-3544CDABB80D
Monoclonal antibody (mAb)-based cancer therapy: Is it time to reevaluate dosing strategies?
P2860
Q30423909-A737501C-33A8-40CE-BBA9-3544CDABB80D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30423909-A737501C-33A8-40CE-BBA9-3544CDABB80D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
737b66c18dd8da1001bf5400cc491d43f08ea6e0
P2860
Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.